Cargando…

Programmed Chemotherapy for Patients with Metastatic Unresectable Gastric Cancer

BACKGROUND: Recent advances in the treatment of metastatic unresectable gastric cancers (MGC) include the development of new antitumor drugs and new regimens for their use. However, the selection of individually designed regimens by gastric cancer (GC) subtype remains problematic. Here, we investiga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shinoda, Masataka, Ando, Takafumi, El-Omar, Emad M., Takashi, Hitomi, Suzuki, Takahisa, Murayama, Mutsumi, Morise, Kazuhiro, Goto, Hidemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383684/ https://www.ncbi.nlm.nih.gov/pubmed/22761692 http://dx.doi.org/10.1371/journal.pone.0038652

Ejemplares similares

Cerebral air embolism as a complication of peptic ulcer in the gastric tube: case report
por: Suzuki, Takahisa, et al.
Publicado: (2011)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

Novel application of low pH-dependent fluorescent dyes to examine colitis
por: Ishiguro, Kazuhiro, et al.
Publicado: (2010)

GERANYLGERANYLACETONE ATTENUATES CISPLATIN-INDUCED REDUCTIONS IN CELL VIABILITY BY SUPPRESSING THE ELEVATION OF INTRACELLULAR P53 CONTENT WITHOUT HEAT SHOCK PROTEIN INDUCTION
por: HASEGAWA, MOTOFUSA, et al.
Publicado: (2012)

Clinical Complete Response after Chemotherapy and Palliative Surgery for Unresectable Gastric Cancer
por: Shishida, Masayuki, et al.
Publicado: (2020)

Management of Bleeding from Unresectable Gastric Cancer
por: Kawabata, Hideaki, et al.
Publicado: (2019)

Treatment features of systemic chemotherapy in young adults with unresectable advanced or recurrent gastric cancer
por: Nakayama, Izuma, et al.
Publicado: (2018)

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
por: Takayama, T, et al.
Publicado: (2007)

Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study
por: Nakano, Takashi, et al.
Publicado: (2020)

HEPATIC PORTAL VENOUS GAS FOLLOWING COLONOSCOPY IN A PATIENT WITH CROHN’S DISEASE
por: UJIHARA, MASAKI, et al.
Publicado: (2013)

Grb2-associated binder 1 polymorphism was associated with the risk of Helicobactor pylori infection and gastric atrophy
por: Goto, Yasuyuki, et al.
Publicado: (2006)

NO ASSOCIATION BETWEEN ANGIOTENSIN I CONVERTING ENZYME (ACE) I/D POLYMORPHISM AND GASTRIC CANCER RISK AMONG JAPANESE
por: HIBI, SATOSHI, et al.
Publicado: (2011)

Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
por: Urakawa, Hiroshi, et al.
Publicado: (2020)

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer
por: Sasaki, Yasutsuna, et al.
Publicado: (2014)

Images of colonic real-time tissue sonoelastography correlate with those of colonoscopy and may predict response to therapy in patients with ulcerative colitis
por: Ishikawa, Daisuke, et al.
Publicado: (2011)

Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer
por: Zhang, Caihua, et al.
Publicado: (2012)

Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer
por: Yeh, Yung-Sung, et al.
Publicado: (2020)

Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy
por: Wang, Jin, et al.
Publicado: (2020)

A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy
por: Iwasaki, Hiroyuki, et al.
Publicado: (2020)

Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
por: Kim, Miso, et al.
Publicado: (2017)

Importance of appropriate pharmaceutical management in pregnant women with ulcerative colitis
por: Ujihara, Masaki, et al.
Publicado: (2013)

Propensity-score-matching-based analysis of laparoscopic gastrectomy with neoadjuvant chemotherapy for gastric carcinoma
por: Furuta, Shimpei, et al.
Publicado: (2021)

Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients
por: Bando, Hideaki, et al.
Publicado: (2018)

Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer
por: LIAN, LIAN, et al.
Publicado: (2015)

Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
por: Gigante, Elia, et al.
Publicado: (2022)

Vorinostat in combination with capecitabine plus cisplatin as a first-line chemotherapy for patients with metastatic or unresectable gastric cancer: phase II study and biomarker analysis
por: Yoo, Changhoon, et al.
Publicado: (2016)

Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report
por: Komo, Toshiaki, et al.
Publicado: (2021)

A network meta-analysis protocol of adjuvant chemotherapy for unresectable patients with advanced gastric cancer
por: Li, Long, et al.
Publicado: (2019)

Multiple-line Chemotherapy for a Patient with Unresectable Mucinous Cystic Neoplasm of the Pancreas
por: Miwa, Haruo, et al.
Publicado: (2021)

Hyperthermia with Chemotherapy for Unresectable Gastric Cancer in a Patient with a Vagus Nerve Stimulator Implant: A Case Report
por: Sawai, Hirozumi, et al.
Publicado: (2021)

The combination of systemic chemotherapy and local treatment may improve the survival of patients with unresectable metastatic colorectal cancer
por: Zhao, Jiemin, et al.
Publicado: (2017)

Comprehensive immunotherapy combined with intratumoral injection of zoledronate-pulsed dendritic cells, intravenous adoptive activated T lymphocyte and gemcitabine in unresectable locally advanced pancreatic carcinoma: a phase I/II trial
por: Hirooka, Yoshiki, et al.
Publicado: (2017)

Prognostic impact of fibroblast growth factor receptor 2 gene amplification in patients receiving fluoropyrimidine and platinum chemotherapy for metastatic and locally advanced unresectable gastric cancers
por: Seo, Seyoung, et al.
Publicado: (2016)

Role of Surgical Intervention in Unresectable Non-Small Cell Lung Cancer
por: Suzuki, Shigeki, et al.
Publicado: (2020)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
por: Guchelaar, Niels A. D., et al.
Publicado: (2023)

Prediction of Treatment Outcome of Chemotherapy Using Perfusion Computed Tomography in Patients with Unresectable Advanced Gastric Cancer
por: Lee, Dong Ho, et al.
Publicado: (2019)

Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy
por: Maki, Hidenori, et al.
Publicado: (2019)

Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer
por: WANG, FEN, et al.
Publicado: (2015)

Combined intra-arterial and intravenous chemotherapy for unresectable, advanced gastric cancer has an improved curative effect compared with intravenous chemotherapy only
por: Wang, Jinfeng, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vo1d9pmkga4vigceeka4n6cd7j